CN Patent

CN104870475B — 抗补体C1s抗体和其用途

Assigned to Zhenbei Medical Co ltd · Expires 2019-11-08 · 7y expired

What this patent protects

本公开提供结合补体C1s蛋白的抗体；和编码所述抗体的核酸分子。在一些实施方案中，所述抗补体C1s抗体抑制C1s的蛋白水解活性。本公开还提供包含所述抗体的组合物，及制备和使用所述抗体、核酸分子和组合物的方法。

USPTO Abstract

本公开提供结合补体C1s蛋白的抗体；和编码所述抗体的核酸分子。在一些实施方案中，所述抗补体C1s抗体抑制C1s的蛋白水解活性。本公开还提供包含所述抗体的组合物，及制备和使用所述抗体、核酸分子和组合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104870475B
Jurisdiction
CN
Classification
—
Expires
2019-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Zhenbei Medical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.